What we have learned from the myriad trials
What We Have Learned from the Myriad Trials
- 50 Downloads
KeywordsMemantine AChE Inhibitor Last Observation Carry Forward Mild Patient Disease Assessment Scale Cognitive Subscale
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- 5.Mohs RC, Knopman D, Petersen RC, et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer’s disease assessment scale that broaden its scope. The Alzheimer’s Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997; 11(suppl 2): S13–21.PubMedGoogle Scholar
- 10.Chuang-Stein C. Seize the opportunities Pharmaceutical Statistics 2004; 3, 157–159Google Scholar
© Serdi and Springer Verlag France 2009